Table 3.
Summarized steady state CFD results. Lean: CFD performed with the lean CFD platform. Established: CFD performed with the established CFD. LPA left pulmonary artery, %PFDLPA fraction of total pulmonary blood to LPA, %HFDLPA fraction of hepatic blood to LPA, PL power loss, %WSS area < 0.4 Pa area fraction of wall shear stress < 0.4 Pa, NA not applicable
| Patient group | Steady state CFD results | |||||||
|---|---|---|---|---|---|---|---|---|
| %PFDLPA | %HFDLPA | PL (mW) | %WSS area < 0.4 Pa | |||||
| Lean CFD | Established CFD | Lean CFD | Established CFD | Lean CFD | Established CFD | Lean CFD | Established CFD | |
| TCPC (n = 9) mean ± SD (range) | 37 ± 9.2% (18–52%) | 37 ± 9.5% (18–51%) | 41 ± 22% (13–89%) | 43 ± 23% (18–95%) | 1.9 ± 1.6 (0.27–4.3) | 1.8 ± 1.5 (0.27–4.0) | 29 ± 18% (7.3–49%) | 28 ± 17% (7.3–49%) |
| Glenn (n = 6) mean ± SD (range) | 40 ± 6.6% (31–47%) | 40 ± 6.3% (31–48%) | NA | NA | 0.51 ± 0.17 (0.31–0.70) | 0.53 ± 0.19 (0.30–0.78) | 11 ± 10% (2.9–31%) | 11 ± 9.4% (1.8–30%) |
| All (n = 15) mean ± SD (range) | 38 ± 8.2% (18–52%) | 38 ± 8.5% (31–51%) | 41 ± 22% (13–89%) | 43 ± 23% (18–95%) | 1.3 ± 1.4 (0.27–4.3) | 1.3 ± 1.3 (0.27–4.0) | 22 ± 18% (2.9–49%) | 21 ± 17% (1.8–49%) |